BeritK/iStock via Getty Images The US FDA has granted Fast Track designation to Acadia Pharmaceuticals’ (ACAD) remlifanserin in Alzheimer’s disease psychosis. The asset is currently in phase 2 for Lewy…
Tag:
BeritK/iStock via Getty Images The US FDA has granted Fast Track designation to Acadia Pharmaceuticals’ (ACAD) remlifanserin in Alzheimer’s disease psychosis. The asset is currently in phase 2 for Lewy…
Welcome to AI Investor Picks, your trusted source for investment insights, financial strategies, and business opportunities. We are dedicated to providing cutting-edge information and analysis on a wide range of investment topics, including stocks, cryptocurrency, real estate, finance, and much more.
© 2025 AI Investor Picks – All Rights Reserved